Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Longo, C; Ragazzi, M; Castagnetti, F; Gardini, S; Palmieri, T; Lallas, A; Moscarella, E; Piana, S; Pellacani, G; Zalaudek, I; Argenziano, G.
Inserting ex vivo fluorescence confocal microscopy perioperatively in Mohs micrographic surgery expedites bedside assessment of excision margins in recurrent basal cell carcinoma.
Dermatology. 2013; 227(1):89-92
Doi: 10.1159/000353577
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Zalaudek Iris
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Mohs micrographic surgery can be employed in recurrent basal cell carcinoma, although it is a time-consuming technique. Recently, ex vivo fluorescence confocal microscopy (FCM) has been employed to obtain a fast assessment of tumor margins at the bedside. In our case we successfully employed ex vivo FCM to assess the tumor margins and we treated the persistent tumor with intensity-modulated radiation therapy. Our case demonstrates that a multidisciplinary approach is very efficient in managing complex and recurrent tumors and highlights the benefits of FCM as a new technique that can be used in the surgical theater to speed up the entire procedure.
- Find related publications in this database (using NLM MeSH Indexing)
-
Aged, 80 and over -
-
Carcinoma, Basal Cell - pathology
-
Fluorescence -
-
Humans -
-
Male -
-
Microscopy, Confocal -
-
Mohs Surgery - methods
-
Neoplasm Recurrence, Local - pathology
-
Neoplasm, Residual -
-
Point-of-Care Systems -
-
Radiotherapy, Intensity-Modulated -
-
Skin Neoplasms - pathology
- Find related publications in this database (Keywords)
-
Basal cell carcinoma
-
Confocal microscope